Skip to main content
An official website of the United States government

Drug Development Consultation Service

The NCI Developmental Therapeutics Program and Cancer Imaging Program provides a Drug Development Consultation Service to investigators from academia or small biotech companies looking for assistance with preclinical development of small molecule, biological, or imaging drugs for cancer. 

The service typically consists of a one-hour call that could assist you with:

  • Updated:

If you would like to reproduce some or all of this content, see Reuse of NCI Information for guidance about copyright and permissions. In the case of permitted digital reproduction, please credit the National Cancer Institute as the source and link to the original NCI product using the original product's title; e.g., “Drug Development Consultation Service was originally published by the National Cancer Institute.”